Cardiovascular Research Foundation pays tribute to individualized medicine pioneer Eric Topol

La Jolla, CA – Eric Topol, MD, founder and director of the Scripps Research Translational Institute, was honored on December 6 by the Cardiovascular Research Foundation (CRF) for his contributions in genomic and digital technologies to transform the practice of medicine.

“I’m deeply appreciative of this recognition from my peers at CRF,” says Topol. “These are exciting times in medicine, where advances in technologies such as artificial intelligence have the potential to completely revolutionize the way medicine is practiced, making it both more individualized and the potential of restoring the doctor-patient relationship.”

Topol, who is Executive Vice President of Scripps Research and a cardiologist, merges genomics and digital medicine with artificial intelligence to tailor medicine to the individual. Over the course of his career, he has led studies that have shaped contemporary treatment for heart disease, including identifying key genes associated with heart attack.   

His current research focuses on accelerating the application of artificial intelligence in medicine and biomedical research.

As a physician-researcher, he has published over 1,200 peer-reviewed articles, with more than 250,000 citations. In the last seven years he has published three books on the future of medicine, covering digitization, democratization and deep learning.

The Cardiovascular Research Foundation is a nonprofit research and educational organization dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease.